ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

Seer Places Survival Now at Least At 45 Percent, Could Be As High As 50 Percent For 1973-79 Patients

December 4, 1981

Ten Is The New 12: Medicare Lowers Hemoglobin Targets For ESA Use.

August 3, 2007

In Brief: GAO Studying Cancer Program So Congress Will Have Own Data; NCI Job Freeze Still Hurts Program

February 21, 1975

Virus Program Changes reviews Subcommittee Report Set Fro June

November 23, 1974

In Brief: Cancer Act renewal, Appropriations Bill Caught In Squeeze Between Conventions

August 1, 1980

Old MSK Grant Reprogrammed, NIC Makes Final 1985 Construction Awards

July 5, 1985